Changes in benign tissue next to prostate tumors may predict biochemical recurrence of cancer, scientists find
Changes in benign tissues next to prostate tumors may provide an early warning for patients at higher risk...
cancer
Drug candidate shrinks tumor when delivered by plant virus nanoparticle
Phenanthriplatin outperformed cisplatin in mouse model of triple-negative breast cancer when encapsulated into nanocarrier In a pair of...
Researchers developing quick, inexpensive test to assess ER+ breast cancers
National Cancer Institute awards $3.3 million to develop digital image analytics Researchers from Case Western Reserve University are...
Watch livestream of White House’s Cleveland Cancer Moonshot Summit
Tune in Wednesday, June 29, as cancer researchers doctors, scientists, philanthropists, community oncologists, advocates, patients, and survivors come...
Cleveland researchers developing GPS for rectal cancer surgery
Risk score would determine who would benefit from chemoradiation alone Researchers estimate that, in the United States annually,...
Researchers’ findings offer promise for the development of new treatments for chronic pain and cancer
Mapping of the full-length TRPV2 protein structure could advance design of innovative pharmaceutical compounds A team led by...
Music department hosts concert to help blow cancer away, one note at a time
When Ryan Anthony first felt sharp pains in his ribs while blowing into his trumpet, he never imagined...
CWRU researchers identify significant mutational targets in colon cancer
Research may offer clue into biologic role of these genes in tumor progression Little is known about the...
New technology quantifies effects of prostate tumor laser ablation
Effort to understand risks of treatment, and prognostic clues to long-term outcomes Prostate cancers are either low-grade, low-risk...
Relay for Life to bring campus community together to fight back against cancer April 16
This year, the campus community will come together once again for Relay for Life Saturday, April 16, at...